SSA
TBPH icon

Schonfeld Strategic Advisors’s Theravance Biopharma TBPH Stock Holding History

Schonfeld Strategic Advisors’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,555
Closed -$310K – 2671
2025
Q4 		$310K Buy
+16,555
New +$275K ﹤0.01% 1571
2023
Q4 		– Sell
-57,426
Closed -$496K – 2207
2023
Q3 		$496K Buy
57,426
+39,350
+218% +$380K ﹤0.01% 1209
2023
Q2 		$187K Buy
+18,076
New +$200K ﹤0.01% 1588
2023
Q1 		– Sell
-29,160
Closed -$327K – 2644
2022
Q4 		$327K Buy
+29,160
New +$306K ﹤0.01% 1751

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.43B AUM 42.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.1B AUM 12.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return